GPT and hypertriglyceridemia: Dietary nutritional supplement consumption was independently associated with ALT elevation (AOR, 1.11; 95% CI, 1.03–1.20), FIB-4 ≥ 1.45 (AOR, 1.10; 95% CI, 1.02–1.19), and APRI ≥ 0.30 (AOR, 1.19; 95% CI, 1.11–1.27) in participants without hypertriglyceridemia (Figure 3).